Sector : Pharmaceuticals and health care | Midcap | BSE
Date Time | Announcment |
|---|---|
| May 13, 2026, 12:55 AM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| May 13, 2026, 12:45 AM IST | Anthem Biosciences - Board Meeting Intimation for Approve The Standalone And Consolidated Financial Results For The Quarter A |
| May 01, 2026, 1:01 AM IST | Anthem Biosciences - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 22, 2026, 11:04 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s |
| Apr 22, 2026, 10:49 PM IST | Anthem Biosciences - Announcement Under Regulation 30 Of LODR-Update In The Outcome Of The Board Meeting Held On April 22, 20 |
| Apr 07, 2026, 12:09 AM IST | Anthem Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 14, 2026, 12:05 AM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Cessation |
| Feb 09, 2026, 10:02 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Feb 06, 2026, 1:09 AM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) |
| Feb 05, 2026, 11:33 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
1 of 5 pages
✕
Market Pulse